Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas

Breast

Volumn 15, Issue 1, 2006, Pages 81-89

  Malara, Natalia M ^a   Leotta, A ^b   Sidoti, A ^a   Lio, S ^b   D''Angelo, R ^a   Caparello, B ^b   Munao, F ^a   Pino, F ^a   Amato, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Lamezia Terme Hospital   (Italy)

Author keywords

Breast cancer; CCND1; Oestrogen receptors; Postmenopausal age; Proliferation; Senescence

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; KI 67 ANTIGEN;

ADULT; AGED; AGING; ARTICLE; CANCER CELL; CANCER INCIDENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL MODEL; TUMOR VOLUME;

EID: 32244447560     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2004.12.008     Document Type: Article

References (26)

1. S.E. Reid M.S. Murthy M. Kaufman E.F. Scanlon Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer Br J Surg 83 1996 1037-1046
2. R.J. Santen D. Leszczynski N. Tilson Mallet Enzymatic control of estrogen production in human breast cancer: Relative significance of aromatase versus sulfatase pathways Ann NY Acad Sci 464 1986 126-137
3. A.A. van Landeghem J. Poortman M. Nabuurs J.H. Thijssen Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue Cancer Res 45 1985 2900-2906
4. J. Fishman J.S. Nisselbaum C.J. Menendez-Botet M.K. Schwartz Estrone and estradiol content in human breast tumours: Relationship to estradiol receptors J Steroid Biochem 8 1977 893-896
5. L.I. Talley W.E. Grizzle J.W. Waterbor D. Brown H. Weiss A.R. Frost Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women Int J Cancer 98 2002 118-127
6. A.J. Nixon D. Neuberg D.F. Hayes et al. Relationship of patient age to pathologic features of tumour and prognosis for patients with stage I or II breast cancer J Clin Oncol 12 1994 888-894
7. J.M. Elwood W. Godolphin Estrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients Br J Cancer 42 1980 635-644
8. E. Skasko Z. Paszko B. Bielinska A. Kluska Epidermal growth factor receptor and estrogen and progesterone receptors in breast cancer of premenopausal and postmenopausal patients Tumori 80 1994 56-60
9. Albain KS, Allred DC, Clark GM. Breast cancer outcome and predictors of outcome: Are there age differentials? J Natl Cancer Inst Monogr 1994; 35-42
10. J.S. Meyer M.U. Prey D.S. Babcock R.W. McDivitt Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study Lab Invest 54 1986 41-51
11. U. Veronesi E. Marubini M. Del Vecchio et al. Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events (see comments) J Natl Cancer Inst 87 1995 19-27
12. J. Kollias C.W. Elston I.O. Ellis J.F. Robertson R.W. Blamey Early onset breast cancer histopathological and prognostic considerations Br J Cancer 75 1997 1318-1323
13. A. de la Rochefordiere B. Asselain F. et al. Campana Age as prognostic factor in premenopausal breast carcinoma (see comments) Lancet 341 1993 1039-1043
14. M. Chung H.R. Chang K.I. Bland H.J. Wanebo Younger women with breast carcinoma have a poorer prognosis than older women Cancer 77 1996 97-103
15. R. Yancik L.G. Ries J.W. Yates Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival Cancer 63 1989 976-981
16. W.E. Grizzle R.B. Myers U. Manne et al. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia M. Hanausek Z. Walaszek John Walker's methods in molecular medicine-tumour marker protocols 1998 Humana Press Totowa, NJ 143-160
17. A.R. Frost D. Sparks W.E. Grizzle Methods of antigen recovery vary in their usefulness in umasking specific antigens in immunohistochemistry Appl Immunohistochem Molec Morphol 8 2000 236-243
18. P.A. Ellis A. Makris S.A. Burton et al. Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas Br J Cancer 73 1996 640-643
19. F. Pesarini Multivariate permutation testes with application in biostatistics 2001 Wiley Chichester
20. M.P. Coleman G. Gatta A. Verdecchia et al. EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century Ann Oncol 14 2003 v128-v149
21. N.H. Nielsen S.O. Emdin J. Cajander G. Landberg Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein Oncogene 14 1997 295-304
22. Y. Imai C.K. Leung H.G. Friesen R.P. Shiu Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture Cancer Res 42 1982 4394-4398
23. S.W. McLeskey J. Kurebayashi S.F. Honig et al. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice Cancer Res 53 1993 2168-2177
24. I. Bieche M. Olivi C. Nogues M. Vidaud R. Lidereau Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays Br J Cancer 86 2002 580-586
25. N.E. Sharpless R.A. De Pinho Telomeres, stem cells, senescence, and cancer J Clin Invest 113 2004 160-168
26. T. Strachan A.P. Read Human molecular genetics 2nd ed 1999 Bios Scientific Publishers Oxford p. 434-7